CHRONIC HEPATITIS B INFECTION
Clinical trials for CHRONIC HEPATITIS B INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS B INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS B INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hepatitis b drug shows promise in Mid-Stage trial
Disease control Recruiting nowThis study tests a new daily pill, ALG-000184, against a standard hepatitis B drug (tenofovir) in 200 adults with chronic hepatitis B. The goal is to see if the new drug can better lower the amount of virus in the blood after 48 weeks. Participants must have untreated hepatitis B…
Matched conditions: CHRONIC HEPATITIS B INFECTION
Phase: PHASE2 • Sponsor: Aligos Therapeutics • Aim: Disease control
Last updated May 26, 2026 10:09 UTC
-
New hepatitis b drug tested in kidney patients
Knowledge-focused Recruiting nowThis early-stage study looks at how the body processes a single dose of pevifoscorvir sodium (ALG-000184) in people with chronic hepatitis B who have different levels of kidney function. About 30 adults with severe, mild, moderate, or no kidney impairment will take part. The goal…
Matched conditions: CHRONIC HEPATITIS B INFECTION
Phase: PHASE1 • Sponsor: Aligos Therapeutics • Aim: Knowledge-focused
Last updated May 26, 2026 10:07 UTC